Comprehensive Money Management Services LLC Sells 289 Shares of SPDR S&P Biotech ETF $XBI

Comprehensive Money Management Services LLC lowered its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.2% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 4,353 shares of the exchange traded fund’s stock after selling 289 shares during the period. Comprehensive Money Management Services LLC’s holdings in SPDR S&P Biotech ETF were worth $361,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. DHJJ Financial Advisors Ltd. bought a new position in SPDR S&P Biotech ETF in the 2nd quarter worth $25,000. Provident Wealth Management LLC boosted its holdings in SPDR S&P Biotech ETF by 3,000.0% in the 1st quarter. Provident Wealth Management LLC now owns 310 shares of the exchange traded fund’s stock worth $25,000 after buying an additional 300 shares during the period. Garrison Bradford & Associates Inc. bought a new position in SPDR S&P Biotech ETF in the 1st quarter worth $39,000. Compass Wealth Management LLC boosted its holdings in SPDR S&P Biotech ETF by 46.0% in the 1st quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock worth $51,000 after buying an additional 200 shares during the period. Finally, Golden State Wealth Management LLC boosted its holdings in SPDR S&P Biotech ETF by 100.0% in the 1st quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock worth $52,000 after buying an additional 319 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock opened at $104.99 on Friday. The company has a fifty day moving average of $93.98 and a 200 day moving average of $85.77. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $107.26. The company has a market capitalization of $6.39 billion, a P/E ratio of 11.47 and a beta of 0.97.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.